Search Results - "Santos, G W"

Refine Results
  1. 1

    Blue and red light photoemitters as approach to inhibit Staphylococcus aureus and Pseudomonas aeruginosa growth by Galo, I D C, Prado, R P, Santos, W G Dos

    Published in Brazilian journal of biology (2022)
    “…The ability of pathogenic bacteria acquire resistance to the existing antibiotics has long been considered a dangerous health risk threat. Currently, the use…”
    Get full text
    Journal Article
  2. 2

    BPA toxicity during development of zebrafish embryo by Scopel, C F V, Sousa, C, Machado, M R F, Santos, W G Dos

    Published in Brazilian journal of biology (01-03-2021)
    “…Bisphenol A (BPA) is a monomer used in the production of polycarbonate, a polymer commonly found in plastics, epoxy resins and thermal papers. The presence of…”
    Get full text
    Journal Article
  3. 3

    Staphylococcus aureus growth delay after exposure to low fluencies of blue light (470 nm) by Galo, I D C, Lima, B E De, Santos, T G, Braoios, A, Prado, R P, Santos, W G Dos

    Published in Brazilian journal of biology (01-05-2021)
    “…Antibiotic resistance is one of the greatest challenges to treat bacterial infections worldwide, leading to increase in medical expenses, prolonged hospital…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Caffeine metabolites not caffeine protect against riboflavin photosensitized oxidative damage related to skin and eye health by Scurachio, R.S., Mattiucci, F., Santos, W.G., Skibsted, L.H., Cardoso, D.R.

    “…Caffeine metabolites were found to bind riboflavin with dissociation constant in the millimolar region by an exothermic process with positive entropy of…”
    Get full text
    Journal Article
  6. 6

    Clinical Toxicity of Cryopreserved Bone Marrow Graft Infusion by Davis, Janice M., Rowley, Scott D., Braine, Hayden G., Piantadosi, Steven, Santos, George W.

    Published in Blood (01-02-1990)
    “…We prospectively evaluated infusion-related toxicities in 82 recipients of autologous bone marrow grafts. The grafts were cryopreserved in 10%…”
    Get full text
    Journal Article
  7. 7

    Astaxanthin diferulate as a bifunctional antioxidant by Papa, T B R, Pinho, V D, do Nascimento, E S P, Santos, W G, Burtoloso, A C B, Skibsted, L H, Cardoso, D R

    Published in Free radical research (01-01-2015)
    “…Astaxanthin when esterified with ferulic acid is better singlet oxygen quencher with k2 = (1.58 ± 0.1) 10(10) L mol(-1)s(-1) in ethanol at 25°C compared with…”
    Get more information
    Journal Article
  8. 8

    Evidence of a Graft-Versus-Lymphoma Effect Associated With Allogeneic Bone Marrow Transplantation by Jones, Richard J., Ambinder, Richard F., Piantadosi, Steven, Santos, George W.

    Published in Blood (01-02-1991)
    “…The existence of an immunologic antileukemia reaction associated with allogeneic bone marrow transplantation (BMT) is well established. However, a similar…”
    Get full text
    Journal Article
  9. 9

    Herpes Zoster Infection After Autologous Bone Marrow Transplantation by Schuchter, Lynn M., Wingard, John R., Piantadosi, Steven, Burns, William H., Santos, George W., Saral, Rein

    Published in Blood (01-09-1989)
    “…One hundred fifty-three patients who underwent autologous bone marrow transplant (ABMT) were studied retrospectively to determine the frequency, outcome, and…”
    Get full text
    Journal Article
  10. 10

    Bronchiolitis Obliterans in Bone Marrow Transplantation and Its Relationship to Chronic Graft-v-Host Disease and Low Serum IgG by Holland, H. Kent, Wingard, John R., Beschorner, William E., Saral, Rein, Santos, George W.

    Published in Blood (01-08-1988)
    “…The records of 549 bone marrow transplant (BMT) patients at The Johns Hopkins Oncology Center during a 9-year period were reviewed to determine the incidence…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The development of busulfan/cyclophosphamide preparative regimens by Santos, G W

    Published in Seminars in oncology (01-08-1993)
    “…Bone marrow transplantation (BMT) preparative regimens consisting of busulfan (Bu) and cyclophosphamide (Cy) were developed as an alternative to preparative…”
    Get more information
    Journal Article
  13. 13

    Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers by Chen, T L, Vogelsang, G B, Petty, B G, Brundrett, R B, Noe, D A, Santos, G W, Colvin, O M

    Published in Drug metabolism and disposition (01-07-1989)
    “…The plasma pharmacokinetics and urinary excretion of thalidomide have been evaluated in eight healthy male volunteers receiving a single oral dose of 200 mg…”
    Get more information
    Journal Article
  14. 14

    Venoocclusive disease of the liver following bone marrow transplantation by Jones, R J, Lee, K S, Beschorner, W E, Vogel, V G, Grochow, L B, Braine, H G, Vogelsang, G B, Sensenbrenner, L L, Santos, G W, Saral, R

    Published in Transplantation (01-12-1987)
    “…Review of 235 consecutive patients undergoing bone marrow transplantation was performed in order to define the clinical syndrome of venoocclusive disease of…”
    Get more information
    Journal Article
  15. 15

    Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution by GLAZIER, A, TUTSCHKA, P. J, FARMER, E. R, SANTOS, G. W

    Published in The Journal of experimental medicine (01-07-1983)
    “…Lethally irradiated rats treated with cyclosporin A (CsA) for 20-40 d develop classic graft-versus-host disease (GVHD) when reconstituted with syngeneic or…”
    Get full text
    Journal Article
  16. 16

    Thalidomide for the Treatment of Chronic Graft-versus-Host Disease by Vogelsang, Georgia B, Farmer, Evan R, Hess, Allan D, Altamonte, Viki, Beschorner, William E, Jabs, Douglas A, Corio, Russell L, Levin, L. Stefon, Colvin, O. Michael, Wingard, John R, Santos, George W

    Published in The New England journal of medicine (16-04-1992)
    “…CHRONIC graft-versus-host disease (GVHD) is the main late complication of allogeneic bone marrow transplantation, occurring in approximately 40 percent of…”
    Get full text
    Journal Article
  17. 17

    Cytomegalovirus Infection After Autologous Bone Marrow Transplantation With Comparison to Infection After Allogeneic Bone Marrow Transplantation by Wingard, John R., Chen, Donald Yen-Hung, Burns, William H., Fuller, Donald J., Braine, Hayden G., Yeager, Andrew M., Kaiser, Herbert, Burke, Philip J., Graham, Michael L., Santos, George W., Saral, Rein

    Published in Blood (01-05-1988)
    “…Cytomegalovirus (CMV) infection was detected in 65 of 143 (45%) autologous bone marrow transplant (BMT) patients. CMV pneumonitis occurred in only 2% of the…”
    Get full text
    Journal Article
  18. 18

    Bone Marrow Graft Engineering by Counterflow Centrifugal Elutriation: Results of a Phase I-II Clinical Trial by Wagner, J.E., Santos, G.W., Noga, S.J., Rowley, S.D., Davis, J., Vogelsang, G.B., Farmer, E.R., Zehnbauer, B.A., Saral, R., Donnenberg, A.D.

    Published in Blood (15-03-1990)
    “…In an attempt to reduce the incidence and severity of acute graft-versus-host disease (GVHD), we have decreased the number of bone marrow (BM) lymphocytes in…”
    Get full text
    Journal Article
  19. 19

    Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants by Arthur, R R, Shah, K V, Baust, S J, Santos, G W, Saral, R

    Published in The New England journal of medicine (24-07-1986)
    “…Fifty-three recipients of bone marrow transplants were monitored prospectively for urinary excretion of human polyomaviruses by enzyme-linked immunosorbent…”
    Get more information
    Journal Article
  20. 20

    Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation by GROCHOW, L. B, JONES, R. J, BRUNDETT, R. B, BRAINE, H. G, TIAN-LING CHEN, SARAL, R, SANTOS, G. W, COLVIN, O. M

    “…Busulfan is an alkylating agent that is widely used in preparative regimens for bone marrow transplantation (BMT). We developed a high-performance liquid…”
    Get full text
    Journal Article